| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |